Bill
Bill > SB2019
TN SB2019
TN SB2019AN ACT to amend Tennessee Code Annotated, Title 33 and Title 53, relative to the treatment of opiate addiction.
summary
Introduced
01/25/2024
01/25/2024
In Committee
Crossed Over
03/25/2024
03/25/2024
Passed
04/15/2024
04/15/2024
Dead
Signed/Enacted/Adopted
05/09/2024
05/09/2024
Introduced Session
113th General Assembly
Bill Summary
As enacted, makes changes to the law relative to prescribing buprenorphine products. - Amends TCA Title 33 and Title 53.
AI Summary
This bill makes changes to the law in Tennessee relative to prescribing buprenorphine products, which are used to treat opioid addiction. It amends the definition of "nonresidential office-based opiate treatment facility" to exclude certain facilities, and updates requirements for healthcare providers who prescribe buprenorphine products, including increasing the number of patients they can treat and the number of buprenorphine products they can prescribe without naloxone. The bill takes effect on July 1, 2024.
Committee Categories
Health and Social Services
Sponsors (5)
Last Action
Effective date(s) 07/01/2024 (on 05/09/2024)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://wapp.capitol.tn.gov/apps/Billinfo/default.aspx?BillNumber=SB2019&ga=113 |
| BillText | https://publications.tnsosfiles.com/acts/113/pub/pc0808.pdf |
| Fiscal Memo for SA0702 (15859) | https://www.capitol.tn.gov/Bills/113/Fiscal/FM2580.pdf |
| Amendment 1-0 to SB2019 | https://www.capitol.tn.gov/Bills/113/Amend/SA0702.pdf |
| Fiscal Note - HB2060 | https://www.capitol.tn.gov/Bills/113/Fiscal/HB2060.pdf |
| BillText | https://www.capitol.tn.gov/Bills/113/Bill/SB2019.pdf |
Loading...